Table 3.
The occurrence of adverse events in B-ACT group was low and pharyngeal discomfort was more common in younger patients.
| B-ACT related adverse events | All | Age |
Sex |
||||
|---|---|---|---|---|---|---|---|
| <65 years | ≥65 years | p | Female | Male | p | ||
| N | 141 | 104 | 37 | 93 | 48 | ||
| Nausea | 8 (5·7%) | 6 (5·8%) | 2 (5·4%) | 0·94 | 6 (5·8%) | 2 (5·4%) | 0·94 |
| Chest discomfort | 15 (10·6%) | 12 (11·5%) | 3 (8·1%) | 0·56 | 7 (7·5%) | 8 (16·7%) | 0·095 |
| Pharyngeal discomfort | 46 (32·6%) | 39 (37·5%) | 7 (18·9%) | 0·038 | 29 (31·2%) | 17 (35·4%) | 0·61 |
| Fever | 5 (3·6%) | 4 (3·9%) | 1 (2·7%) | 0·75 | 2 (2·2%) | 3 (6·3%) | 0·21 |
| Blood in sputum | 15 (10·6%) | 12 (11·5%) | 3 (8·1%) | 0·56 | 10 (10·8%) | 5 (10·4%) | 0·95 |
Data are summarized as n (percentage) for categorical data. Categorical variables were compared by chi-square test. Statistical significance was considered when the two-tailed P < 0·05. ACT, Airway Clearance Therapy; B, Bronchoscopic.